ARTICLE | Financial News

Vitae sets IPO terms

September 9, 2014 2:14 AM UTC

Vitae Pharmaceuticals Inc. (Fort Washington, Pa.) set the terms for its IPO on NASDAQ. The company plans to sell 5 million shares at $11-$13. At the $12 midpoint, Vitae would raise $60 million and be valued at $186 million. The company filed to raise up to $55 million in the offering last month. Stifel; BMO Capital Markets; JMP Securities; and Wedbush PacGrow are underwriters. ...